The Von Hippel-Lindau Tumor Suppressor Complex and Regulation of Hypoxia-Inducible Transcription. Retinoblastoma Tumor Suppressor and Genome Stability. The Abl Family Kinases: Mechanisms of Regulation and Signaling. Cellular Immunity to the Her-2/neu Proto-oncogene. A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance. Cell Volume and Ion Changes During Apoptotic Cell Death. Mitochondria and Apoptosis: New Therapeutic Targets.
Researchers and students in the basic and clinical science of cancer biology and oncology, genetics, immunology, pharmacology, cell and molecular biology.
- No. of pages:
- © Academic Press 2002
- 30th September 2002
- Academic Press
- eBook ISBN:
- Hardcover ISBN:
@from:PRAISE FOR THE SERIES @qu:"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences." @source:AMERICAN SCIENTIST @qu:"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced." @source:JOURNAL OF MEDICINAL CHEMISTRY @qu:"This is a series that has a long tradition of excellence in the field of cancer biology." @source:DOODY'S PUBLISHING REVIEWS
Director, Van Andel Research Institute, Grand Rapids, MI, USA NCI-Frederick Cancer Research Facility Frederick, Maryland ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland
Karolinska Insitutet, Stockholm, Sweden